ALKS vs BXP
Alkermes Plc (ALKS) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. BXP currently screens at market cap $12.12B.
Not investment advice. Open the ALKS and BXP stock pages for the full models.
Not investment advice.